🎓 Education
Dr. Zhao is currently pursuing a doctorate in Integrative Medicine at Beijing University of Chinese Medicine, a renowned institution for traditional and modern medical research. This academic journey has equipped Dr. Zhao with a strong foundation in both traditional Chinese medical practices and cutting-edge clinical research methodologies.
💼 Experience
With extensive research experience, Dr. Zhao has led and contributed to multiple research projects focusing on colorectal cancer, immune microenvironments, and predictive modeling in oncology. Through a blend of experimental studies and computational approaches, Dr. Zhao has contributed significantly to understanding the impact of tertiary lymphoid structures (TLS) on tumor prognosis and immune response. In addition to academic research, Dr. Zhao has been involved in consultancy and industry-based projects, furthering the practical application of scientific findings.
🏆 Awards and Honors
Dr. Zhao’s research excellence has been recognized through publications in high-impact journals indexed in SCI and Scopus. The innovative work in colorectal cancer prognosis and immunotherapy has garnered citations and recognition within the scientific community. As an active contributor to the field, Dr. Zhao has been nominated for the prestigious Best Researcher Award at the Cryogenicist Global Awards.
🔬 Research Focus
Dr. Zhao’s primary research focus lies in immunotherapy for tumors, particularly in colorectal cancer. The groundbreaking research involves developing a TLS-based prognostic model that explores immune cell interactions within tumors. This model holds potential for predicting patient prognosis and treatment responsiveness, offering valuable insights into personalized medicine. Furthermore, Dr. Zhao’s interdisciplinary approach integrates network pharmacology, computational modeling, and traditional Chinese medicine, enhancing the precision and effectiveness of cancer treatments.
🔗 Publications
The Impact of Tertiary Lymphoid Structures on Tumor Prognosis and the Immune Microenvironment in Colorectal Cancer. Biomedicines, 2025; 13(3):539
🔗 DOI: 10.3390/biomedicines13030539
Limonin ameliorates indomethacin-induced intestinal damage and ulcers through Nrf2/ARE pathway. Immun Inflamm Dis, 2023; 11(2):e787
🔗 DOI: 10.1002/iid3.787
Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis. Integr Med Res, 2021; 10(3):100726
🔗 DOI: 10.1016/j.imr.2021.100726
Deciphering the Mechanism of Siwu Decoction Inhibiting Liver Metastasis by Integrating Network Pharmacology and In Vivo Experimental Validation. Integr Cancer Ther, 2024; 23:15347354241236205
🔗 DOI: 10.1177/15347354241236205
🔚 Conclusion
Dr. Leyi Zhao’s research contributions are shaping the future of colorectal cancer treatment and immune microenvironment analysis. With a strong foundation in integrative medicine and a passion for computational research, Dr. Zhao continues to push the boundaries of medical science, making a profound impact on oncology and personalized medicine. As a nominee for the Best Researcher Award, Dr. Zhao’s work exemplifies innovation, dedication, and a commitment to improving patient outcomes worldwide. 🌍